EC Gynaecology

Objective: Evaluate whether the presence of aneuploid blastocysts is associated with sperm morphology and fragmentation.

Methods: Retrospective, observational and cross-sectional study, which included 352 embryos in blastocyst stage, obtained by intracytoplasmic sperm injection (ICSI) from 131 cycles of patients with implantation failure and who decided to perform preimplantation genetic study of aneuploidy (PGT-A) to the embryos that were transferred to the uterus, in order to improve the implantation rate.

Results: Of the embryos obtained from donated oocytes, only those fertilized with semen diagnosed with teratozoospermia presented aneuploidy (26.6%). The rate of aneuploid embryos was similar when own oocytes were fertilized with semen diagnosed with normozoospermia or teratozoospermia (38.4 vs 37.07%). Finally, no relationship was observed between chromatin damage and sperm morphology.

Conclusion: In patients who fertilize their oocytes with spermatozoa from samples diagnosed with normozoospermia or teratozoospermia, the rate of aneuploid blastocysts will depend mainly on the female factor, this does not rule out the possibility of aneuploid embryos due to the male factor. Different from what was seen in donated oocytes, where embryos obtained from semen diagnosed with teratozoospermia presented a higher rate of aneuploidy.

Keywords: Recurrent Implantation Failure; Recurrent Pregnancy Loss; Sperm Morphology; Sperm Chromatin; PGT-A

1. "Subfecundidad e infertilidad en mujertes mexicanas”. Papeles de Poblacion 12.50 (2006): 277-291.
2. Cabrera M Ramos., et al. “Tasa de éxito en clínicas de fertilidad. Notables difertencias al comparar la información que proporcionan las clínicas de fertilización asisistida en México, la obtenida de los reportes internacionales y la extraída de un estudio de campo en México”. Medicina y Ética2 (2020): 245-265.
3. E Zamora. "¿Como se garantiza la atención obstétrica depués de la reptoducción asistida?”. Ginecología y Obstetricia de México1 (2019): 1-3.
4. W Verpoest., et al. “Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial”. Human Reproduction9 (2018): 1767-1776.
5. S Wei., et al. “Different strategies of preimplantation genetic testing for aneuploidies in women of advanced maternal age: a systematic review and meta-analisis”. Journal of Clinical Medicine 10 (2021): 1-12.
6. Q Shi., et al. “Next-generation secuencing analysis of each blastomere in good-quality embryos: insights into the origins and mechanisms of embryonic aneuploidy in cleave stage embryos”. Journal of Assisted Reproduction and Genetic7 (2020): 1711-1718.
7. F Fiorentino., et al. “Development and validation of a next-generation sequencing-based protocol for 24-chromosome aneuploidy screening of embryo”. Fertility and Sterility 101 (2014): 1375-1382.
8. Sausa R Tavares., et al. “Dual use of Diff Quik Like stain for the simultaneous evalulation of human sperm morphology and cromatin status”. Human Reproduction1 (2009): 28-36.
9. D Gardner and W Schoolcraft. "In vitro culture of human blastocyst”. In: Jansen R, Mortimer D, editions. Toward reproductive certainty: infertility and genetics beyond (1999): 378-388.
10. Bashiri K Ida Halper and R Orvieto. "Recurrent implantation failure-update overview on eriology, diagnosis, treatment and future directions”. Reproductive Biology and Endocrinology121 (2018): 1-18.
11. Oliver P Matallín., et al. “Obesidad como factor pronóstico reproductivo en ciclos de fecundación in vitro-inyección espermática intracitoplasmática”. Progresos de Obstetricia y Ginecología9 (2014): 393-399.
12. M Cozzolino., et al. “Female obesity increases the risk of miscarriage of euploid embryos”. Fertility and Sterility6 (2020): 1495-1502.
13. WHO laboratory manual for the laboratory examination and processing of human semen, Electronic version: World Health Organization, HRP (2021).
14. S Kahraman., et al. “High rates of aneuploidy, mosaicism and abnormal morphokinetic development in cases with low sperm concentration”. Journal of Assisted Reproduction and Genetics 37 (2020): 629-640.
15. M Nijs., et al. “Correlation between male age, WHO sperm parameters, DNA fragmentation, chromatin packaging and outcome in assisted reproduction technology”. First International Journal of Andrology3 (2009): 174-179.
16. N Tarozzi., et al. “Male factor infertility impacts the rate of mosaic blastocysts in cycles of preimplantation genetic testing for aneuploidy”. Journal of Assisted Reproduction and Genetics 36 (2019): 2047-2055.
17. Y Kiseleva., et al. “The Increase in Aneuploidy of Embryos Is Associated with Pathological Morphology of the Sperm”. Russian Journal of Genetics12 (2017): 1378-1381.
18. J Rodriguez., et al. “Does Severe Teratozoospermia Correlate to Embryonic Aneuploidy Rates?”. Fertility and Sterility (2016): 1-5.
19. O Coban., et al. “Evalulation of the impact of sperm morphology on embryo aneuploidy rates in a donor oocyte program”. System Biology in Reproductive Meicine3 (2018): 169-173.
20. Góngora S Sánchez., et al. “Fragmentación del ADN del espermatozoide y su influencia en la fertilidad de pareja”. Revista Mexicana de la Medicina de la Reproducción3 (2011): 105-111.
21. Rodríguez. "Fragmentación del ADN espermático e infertilildad masculina”. Revista Cubana de Endocrinología3 (2017): 1-17.
22. G Young. "What should be done for men with sperm DNA fragmentation?”. Corporate Environmental Risk Management3 (2018): 101-109.
23. Agarwal A Majzoub., et al. “Sperm DNA Fragmentation: A New Guideline for Clinicians”. Male Reproductive Health and Infertility4 (2020): 412-471.
24. E Saucedo-De La Llata., et al. “Fragmentación del ADN espermático: situación actual”. Ginecología y Obstetricia de México3 (2017): 164-189.
25. F Bronet., et al. “Sperm DNA fragmentation index does not correlate with the sperm or embryo aneuploidy rate in recurrent miscarriage or implantation failure patients”. Human Reproduction7 (2012): 1922-1929.
26. J Miller and T Smith. "The effect of intracytoplasmic sperm injection and semen parameters on blastocyst development in vitro”. Human Reproduction5 (2001): 918-924.
27. M Stimpfel., et al. “Conventional IVF improves blastocyst rate and quality compared to ICSI when used in patients with mild or moderate teratozoospermia”. System Biology in Reproductive Medicine6 (2019): 458-464.
28. González P Cancino., et al. “Inyección intracitoplásmica de espermatozoides morfológicamente seleccionados (IMSI) vs inyección intracitoplásmica de espermatozoides (ICSI) en pacientes con falla repetida a ICSI”. Ginecología y Obstetricia de México12 (2010): 652-659.